Status:
COMPLETED
Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Cedars-Sinai Medical Center
Conditions:
Inflammatory Bowel Diseases
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a small, exploratory study that will investigate using an artificial intelligence (AI) and virtual reality (VR), digital wellness application (app) to deliver a mental health support session i...
Detailed Description
The mental health support session is delivered by a virtual reality digital wellness application (app). The app is a Chat GPT-4 powered AI and VR platform called XAIA (eXtended reality Artificially In...
Eligibility Criteria
Inclusion
- 18+ years of age
- Patients with Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
- English-speaking
- Patients with score of 5-14 on General Anxiety Disorder-7 (GAD-7) questionnaire or 5-19 on Patient Health Questionnaire-9 (PHQ-9) within 3 months
- Able to provide written consent
Exclusion
- Unwilling and/or unable to participate
- Non-English speakers
- Self-reported history of severe motion sickness
- The presence of a facial/head deformity that will prohibit comfortably wearing of a VR headset
- Legally blind or deaf
- Having had a seizure in the past year
- Unable to understand the instructions or to consent to participation in the study.
- Those who are pregnant
Key Trial Info
Start Date :
September 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 9 2025
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06575660
Start Date
September 23 2024
End Date
October 9 2025
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637